84 related articles for article (PubMed ID: 2441566)
1. In vitro chemosensitivity testing of squamous cell carcinoma of the head and neck. A preliminary report.
Elprana D; Schwachöfer J; Kuijpers W; van den Broek P; Wagener DJ
Acta Otolaryngol; 1987; 103(5-6):529-36. PubMed ID: 2441566
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic drug sensitivity of squamous cell carcinoma as predicted by an in vitro testing model.
Elprana D; Schwachöfer J; Kuijpers W; Van Den Broek P; Wagener DJ
Anticancer Res; 1989; 9(4):1089-94. PubMed ID: 2479326
[TBL] [Abstract][Full Text] [Related]
3. Chemosensitivity testing of xenografted squamous cell carcinomas of the head and neck region.
Elprana D; Kuijpers W; Wessels JM; Wagener DJ; van den Broek P
Anticancer Res; 1992; 12(6B):2229-39. PubMed ID: 1284201
[TBL] [Abstract][Full Text] [Related]
4. Pharmacodynamics of cisplatin in human head and neck cancer: correlation between platinum content, DNA adduct levels and drug sensitivity in vitro and in vivo.
Welters MJ; Fichtinger-Schepman AM; Baan RA; Jacobs-Bergmans AJ; Kegel A; van der Vijgh WJ; Braakhuis BJ
Br J Cancer; 1999 Jan; 79(1):82-8. PubMed ID: 10408697
[TBL] [Abstract][Full Text] [Related]
5. Polymer chemotherapy for head and neck cancer.
Shikani AH; Domb AJ
Laryngoscope; 2000 Jun; 110(6):907-17. PubMed ID: 10852503
[TBL] [Abstract][Full Text] [Related]
6. Bleomycin induced changes in growth and cell kinetics of a heterotransplanted squamous cell carcinoma of the head and neck.
Wennerberg J
Anticancer Res; 1984; 4(6):419-23. PubMed ID: 6083742
[TBL] [Abstract][Full Text] [Related]
7. Human tumor xenografts in athymic (nude) mice: chemotherapy trials in serially transplanted tumors.
Azar HA; Fernandez SB; Bros LM; Sullivan JL
Ann Clin Lab Sci; 1982; 12(1):51-9. PubMed ID: 6175269
[TBL] [Abstract][Full Text] [Related]
8. Treatment of advanced epidermoid carcinoma of the head and neck using methotrexate, bleomycin and cis-platinum.
Orsini MA; Strauss M; Zaino RJ; Messeih AA; Harvey HA; Lipton A
Trans Pa Acad Ophthalmol Otolaryngol; 1984; 37(1):71-6. PubMed ID: 6204427
[No Abstract] [Full Text] [Related]
9. [Chemosensitivity of human head and neck tumors detected by human tumor clonogenic assay].
Suzuki K; Fujii M; Ishii Y; Mochizuki F; Suzuki K; Yamagata M; Suzuki H; Moriya Y; Abiko Y; Sakabe T
Nichidai Koko Kagaku; 1989 Jun; 15(2):153-6. PubMed ID: 2483253
[TBL] [Abstract][Full Text] [Related]
10. In vivo interaction of cis-platinum and fosfomycin on squamous cell carcinoma.
Tandy JR; Tandy RD; Farris P; Truelson JM
Laryngoscope; 2000 Jul; 110(7):1222-4. PubMed ID: 10892700
[TBL] [Abstract][Full Text] [Related]
11. [Experiences using combination chemotherapy with cis-platinum, bleomycin and methotrexate in the management of advanced squamous cell carcinomas of the head and neck (author's transl)].
Jahnke V
HNO; 1980 Dec; 28(12):405-8. PubMed ID: 6161913
[TBL] [Abstract][Full Text] [Related]
12. The effect of high dose vitamin A on the morphology and proliferative activity of xenograft lung and head and neck cancer.
Mourad WA; Bruner JM; Vallieres E; McName C; Alabdulwahed S; Scott K; Oldring DJ
In Vivo; 1996; 10(3):329-33. PubMed ID: 8797035
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of epidermoid head and neck cancer with cisplatinum/bleomycin vs methotrexate/vindesine].
Schröder M; von Heyden HW; Beyer JH; Klee M
Laryngol Rhinol Otol (Stuttg); 1981 Jun; 60(6):331-3. PubMed ID: 6167831
[TBL] [Abstract][Full Text] [Related]
14. [Chemotherapy in the multi-disciplinary treatment of head and neck tumors: evaluation of a chemosensitivity test].
Saito H
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1744-52. PubMed ID: 3729480
[TBL] [Abstract][Full Text] [Related]
15. p53 mutation and cyclin D1 amplification correlate with cisplatin sensitivity in xenografted human squamous cell carcinomas from head and neck.
Henriksson E; Baldetorp B; Borg A; Kjellen E; Akervall J; Wennerberg J; Wahlberg P
Acta Oncol; 2006; 45(3):300-5. PubMed ID: 16644573
[TBL] [Abstract][Full Text] [Related]
16. [Experimental study on the anti-tumor effects of CDDP derivatives on head and neck squamous cell carcinoma cell lines].
Tsukuda M; Yoshida T; Kubota A; Yanoma S; Watanabe S; Takahashi K; Ono T; Sawaki S
Gan To Kagaku Ryoho; 1988 Sep; 15(9):2811-4. PubMed ID: 3415274
[No Abstract] [Full Text] [Related]
17. Retinoid-induced suppression of squamous cell differentiation in human oral squamous cell carcinoma xenografts (line 1483) in athymic nude mice.
Shalinsky DR; Bischoff ED; Gregory ML; Gottardis MM; Hayes JS; Lamph WW; Heyman RA; Shirley MA; Cooke TA; Davies PJ
Cancer Res; 1995 Jul; 55(14):3183-91. PubMed ID: 7541715
[TBL] [Abstract][Full Text] [Related]
18. Activity of the folate analog 10-ethyl, 10-deaza-aminopterin (10-EdAM) against human head and neck cancer xenografts.
Brown DH; Braakhuis BJ; van Dongen GA; van Walsum M; Bagnay M; Snow GB
Anticancer Res; 1989; 9(6):1549-52. PubMed ID: 2627109
[TBL] [Abstract][Full Text] [Related]
19. Combination of cis-platinum, oncovin, and bleomycin (COB) prior to surgery and/or radiotherapy in advanced untreated epidermoid cancer of the head and neck.
Peppard SB; Al-Sarraf M; Powers WE; Loh JK; Weaver AW
Laryngoscope; 1980 Aug; 90(8 Pt 1):1273-80. PubMed ID: 6157067
[TBL] [Abstract][Full Text] [Related]
20. [Combined radiotherapy with cis- or carboplatin in advanced head and neck tumors].
Zamboglou N; Pape H; Schnabel T; Wurm R; Bannach B; Fürst G; Schmitt G
Strahlenther Onkol; 1989 Sep; 165(9):647-51. PubMed ID: 2678546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
